📊 Evidence-Based Reference

anti-neutrophil cytoplasmic antibodies ethanol-fixed anti-neutrophil cytoplasmic antibodies formalin-fixed

Zeus Scientific

Summary: The device detects anti-neutrophil cytoplasmic antibodies (ANCA) using ethanol and formalin-fixed samples. Primarily used in diagnosing autoimmune vasculitides. Key evidence highlights its diagnostic importance in differentiating vasculitis types.

FDA Clearance Information

Pathway 510K
Decision Date May 7, 2025
Product Code MOB
Device Class Class 2
Evidence 419 studies

The device was cleared by the FDA through the 510k pathway on May 7, 2025. Manufactured by Zeus Scientific, it is classified as a Class 2 device under product code MOB.

What It Is

This device is used to detect anti-neutrophil cytoplasmic antibodies (ANCA) in patient samples. It employs both ethanol-fixed and formalin-fixed methods to identify antibodies associated with autoimmune vasculitides, aiding in the diagnosis and differentiation of conditions like granulomatosis with polyangiitis.

Clinical Applications

Commonly used in clinical settings to diagnose and monitor autoimmune vasculitides such as granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, and microscopic polyangiitis. It provides critical information for distinguishing between these conditions.

Evidence Summary

The literature includes 10 studies, encompassing various study types such as RCTs and retrospective analyses, conducted between 2019 and 2025. These studies focus on the diagnostic utility and technological advancements in ANCA detection.

Reported Outcomes

Published studies report the device's efficacy in accurately detecting ANCA, which is crucial for diagnosing vasculitides. The use of both ethanol and formalin fixation methods enhances diagnostic precision, particularly in distinguishing between different types of vasculitis.

Safety Profile

Reported complications include potential false positives or negatives due to sample handling or fixation methods. However, no significant adverse events directly related to the device's use have been documented in the available literature.

Evidence Limitations

Current evidence is limited by the variability in study designs and the lack of large-scale, multicenter trials. Further research is needed to standardize testing protocols and confirm findings across diverse populations.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for anti-neutrophil cytoplasmic antibodies?

The device is indicated for diagnosing autoimmune vasculitides, including granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, and microscopic polyangiitis.

What outcomes have been reported in clinical studies?

Studies report effective ANCA detection, aiding in the differentiation of vasculitis types, with improved diagnostic accuracy using both ethanol and formalin fixation methods.

What complications have been reported?

Reported complications include potential false results due to sample handling, but no significant adverse events related to the device itself have been noted.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.